ProfileGDS5678 / 1426971_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 78% 78% 78% 89% 77% 77% 79% 76% 77% 77% 78% 79% 77% 76% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 15.3335578
GSM967853U87-EV human glioblastoma xenograft - Control 25.4143478
GSM967854U87-EV human glioblastoma xenograft - Control 35.3732278
GSM967855U87-EV human glioblastoma xenograft - Control 47.2665289
GSM967856U87-EV human glioblastoma xenograft - Control 55.292877
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 15.1065177
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 25.3268579
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 35.1184676
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 45.3019277
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 15.3190277
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 25.3201878
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 35.5797479
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 45.2343177
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 55.0646676